4
Tetrahedron
well as Luis Velasco, Javier Pérez, Hector Rios, María I. Chavez,
Beatriz Quiroz and Mario Alfredo Garcia Carrillo for technical
assistance. J.T. is a fellow of the EDI-IPN and COFAA-IPN
programs.
Table 3. Synthesized exo/endo tetrahydrobenzoxazol-2-ones
11/12.
5. References and notes.
Crystallographic data (excluding structure factors) for the structures in this
paper have been deposited with the Cambridge Crystallographic Data Centre
as supplementary publication nos. CCDC. Copies of the data can be obtained,
free of charge, on application to CCDC, 12 Union Road, Cambridge CB2
CCDC registry number for 8i/9i: 1033700. CCDC registry number for 11a:
1882393.
Ratio
Yield
Adducts
R1
R3
(%)[b]
11/12[a]
12:88
13:87
54:46
53:47
45:55
23:74
<1:99
1.
Aichaoui H, Guenadil F, Kapanda CN, Lambert DM, McCurdy CR,
Poupaert JH. Med Chem Res. 2008; 18: 467–476.
Poupaert J, Carato P, Colacino E. Curr Med Chem. 2005; 12: 877–885.
Tang L, Ban SR, Feng XE, Lin WH, Li QS. Chin Chem Lett. 2010; 21:
63–66.
11a, 12a
11b, 12b
11c, 12c
11d, 12d
11e, 12e
11f, 12f
11g, 12g
4-methylthiophenyl
2,4-dichlorophenyl
4-methoxyphenyl
4-methoxyphenyl
phenyl
4-methylphenyl
4-methylphenyl
4-methylphenyl
phenyl
45
83
61
46
62
56
93
2.
3.
4.
Friebe A, Vilich V, Hennig L, Kluge M, Sicker D. Appl Environ
Microbiol. 1998; 64: 2386–2391.
5.
6.
Soyer Z, Eraç B. J Pharmacol Sci. 2007; 32: 167–171.
Kaplancikli ZA, Turan-Zitouni G, Revial G, Guven K. Arch Pharm
Res. 2004; 27: 1081–1085.
phenyl
4-methylthiophenyl
2,4-dichlorophenyl
4-chlorophenyl
3-methoxyphenyl
7.
8.
9.
Gökhan N, Erdoğan H, Durlu NT, Demirdamar R. Il Farm. 1999; 54:
112–115.
Gökhan-Kelekçi N, Köksal M, Ünüvar S, Aktay G, Erdoğan H. J
Enzyme Inhib Med Chem. 2009; 24: 29–37.
Ucar H, Van derpoorten K, Cacciaguerra S, Spampinato S, Stables JP,
Depovere P, Isa M, Masereel B, Delarge J, Poupaert JH. J Med Chem.
1998; 41: 1138–1145.
[a] Determined by 1H NMR. [b] For the diastereoisomeric mixture.
10. Weinstock J, Gaitanopoulos DE, Stringer OD, Franz RG, Hieble JP,
Kinter LB, Mann WA, Flaim KE, Gessner G. J Med Chem. 1987; 30:
1166–1176.
11. Deng B-L, Cullen MD, Zhou Z, Hartman TL, Buckheit Jr. RW,
Pannecouque C, Clercq ED, Fanwick PE, Cushman M. Bioorg Med
Chem. 2006; 14: 2366–2374.
12. Gerova MS, Stateva SR, Radonova EM, Kalenderska RB, Rusew RI,
Nikolova RP, Chanev CD, Shivachev BL, Apostolova MD, Petrov OI.
Eur J Med Chem. 2016; 120: 121–133.
13. Piomelli, D., Pizzirani, D., Bach, A., Scarpelli, R., Melzig, L., Mor,
M.United States, US20170182009A1 2017.
14. Kalcheva V, Lozanova K, Simov D, Terent’ev PB. Chem Heterocycl
Compd. 1985; 21: 985–987.
15. Ram RN, Soni VK. J Org Chem. 2013; 78: 11935–11947.
16. Bautista R, Bernal P, Montiel L, Delgado F, Tamariz J. Synthesis.
2011; 6: 929–933.
17. González-Romero C, Bernal P, Jiménez F, Cruz MC, Fuentes-Benites
A, Benavides A, Bautista R, Tamariz J. Pure Appl Chem. 2007; 79:
181–191.
18. Mandal AB, Gómez A, Trujillo G, Méndez F, Jiménez HA, Rosales
MJ, Martínez R, Delgado F, Tamariz J. J Org Chem. 1997; 62: 4105–
4115.
19. Nowakowska Z. Eur J Med Chem. 2007; 42: 125–137.
20. Srinivasan B, Johnson TE, Lad R, Xing C. J Med Chem. 2009; 52:
7228–7235.
21. Bazzaro M, Anchoori RK, Mudiam MKR, Issaenko O, Kumar S,
Karanam B, Lin Z, Isaksson Vogel R, Gavioli R, Destro F, Ferretti V,
Roden RBS, Khan SR. J Med Chem. 2011; 54: 449–456.
22. Patil CB, Mahajan SK, Katti SA. ChemInform. 2010; 41: i.
23. Corbett JL, Weavers RT. Synth Commun. 2008; 38: 489–498.
24. Büldt LA, Wenger OS. Chem Sci. 2017; 8: 7359–7367.
25. Nasir SB, Tee JT, Rahman NA, Chee CF. In Flavonoids - From
Biosynthesis to Human Health; G. C. Justino, Ed.; InTech, 2017;
26. Lv H, Mo J, Fang X, Chi YR. Org Lett. 2011; 13: 5366–5369.
27. Fuentes A, Martínez-Palou R, Jiménez-Vázquez HA, Delgado F,
Reyes A, Tamariz J. Monatshefte Für Chem. 2005; 136: 177–192.
28. Palaniappan A, Udhayakumar R, Srinivasan S, Raju C. J Chem Pharm
Res. 2012; 4: 2385.
29. Awasthi SK, Mishra N, Kumar B, Sharma M, Bhattacharya A, Mishra
LC, Bhasin VK. Med Chem Res. 2009; 18: 407–420.
30. Sebti S, Solhy A, Tahir R, Boulaajaj S, Mayoral JA, Fraile JM, Kossir
A, Oumimoun H. Tetrahedron Lett. 2001; 42: 7953–7955.
31. Rayees Ahmad M, Girija Sastry V, Bano N, Anwar S. Arab J Chem.
2016; 9: S931–S935.
Figure 5 ORTEP plot for 11a.
3. Conclusions.
The synthesis is herein described, for the series of 5,6-
substituted 4,5,6,7-tetrahydrobenzoxazol-2-ones 8/9 and 11/12
via a highly regioselective Diels-Alder cycloaddition. The
endo/exo stereoselectivity of compounds 8/9 was dependent on
the solvent, polarity and substituents. An endo preference existed
when using the solvent with the strongest polarity and an exo
preference with the nonpolar solvent, except for the adducts
bearing C6-2,4-dichlorophenyl, C6-2-chlorophenyl or C6-2,3-
dimethoxyphenyl substituents. On the other hand, compounds
11/12 showed endo preference with the nonpolar solvent. The
adduct structures and relative configuration were established
through NMR spectroscopic and X-ray diffraction analyses.
Synthetic applications of these novel compounds are currently
underway, and the results will be reported in due time.
4. Acknowledgments.
Financial support from UAEMéx (project No.4512/2018/CI)
and CONACyT (postgraduate scholarship grant No. 401195) is
gratefully acknowledged. J.T. is thankful to the SIP/IPN (grant
20180198) and CONACYT (grant 178319) for financial support.
The authors would like to thank Dr. Davir González-Calderón,
M. en C. Nieves Zavala-Segovia, and Lizbeth Triana-Cruz
(CCIQS UAEMéx‒UNAM), Instituto de Química UNAM as
32. Fringuelli F, Taticchi A. The Diels-Alder Reaction: Selected Practical
Methods, John Wiley & Sons, 2002.